![Kortfristet Trans No](/news-release/logo/225548/0/225548.jpg?lastModified=12%2F09%2F2016%2022%3A50%3A34&size=2)
Kortfristet Trans Nova lån på 1,5 millioner til Affitech
July 19, 2012 02:00 ET
|
Affitech A/S
København og Oslo, 19 juli 2012, 2012-07-19 08:00 CEST (GLOBE NEWSWIRE) --
Affitech A/S, (NASDAQ OMX: AFFI), der udvikler antistoflægemidler, meddeler, at Trans Nova Investment Limited (Trans Nova),...
![Euro 1.5 million sho](/news-release/logo/225548/0/225548.jpg?lastModified=12%2F09%2F2016%2022%3A50%3A34&size=2)
Euro 1.5 million short term loan provided by Trans Nova
July 19, 2012 02:00 ET
|
Affitech A/S
Copenhagen and Oslo, 19th July, 2012, 2012-07-19 08:00 CEST (GLOBE NEWSWIRE) --
Affitech A/S, (NASDAQ OMX: AFFI), the antibody medicines company, announced today Trans Nova Investment Limited (Trans...
![Nyt tilbud fra Trans](/news-release/logo/225548/0/225548.jpg?lastModified=12%2F09%2F2016%2022%3A50%3A34&size=2)
Nyt tilbud fra Trans Nova som følge af NASDAQ OMX Copenhagen accept af Affitechs anmodning om afnotering
July 17, 2012 04:15 ET
|
Affitech A/S
København og Oslo, 17. juli 2012, 2012-07-17 10:15 CEST (GLOBE NEWSWIRE) --
Affitech A/S, (NASDAQ OMX: AFFI), der udvikler antistoflægemidler, meddeler i dag følgende:
NASDAQ OMX Copenhagen har...
![New offer from Trans](/news-release/logo/225548/0/225548.jpg?lastModified=12%2F09%2F2016%2022%3A50%3A34&size=2)
New offer from Trans Nova following acceptance by NASDAQ OMX Copenhagen of Affitech’s request to delist
July 17, 2012 04:15 ET
|
Affitech A/S
Copenhagen and Oslo, 17th July, 2012, 2012-07-17 10:15 CEST (GLOBE NEWSWIRE) --
Affitech A/S, (NASDAQ OMX: AFFI), the antibody medicines company, announced today the following:
NASDAQ OMX...
![New offer from Trans](/news-release/logo/225548/0/225548.jpg?lastModified=12%2F09%2F2016%2022%3A50%3A34&size=2)
New offer from Trans Nova following accept by NASDAQ OMX Copenhagen of de-listing request from Affitech
July 17, 2012 04:03 ET
|
Affitech A/S
Copenhagen, 17th July, 2012
On behalf of Trans Nova Investments Limited, a press release and an offer document is hereby made public regarding a new voluntary conditional public purchase...
![Fornyet købstilbud f](/news-release/logo/225548/0/225548.jpg?lastModified=12%2F09%2F2016%2022%3A50%3A34&size=2)
Fornyet købstilbud fra Trans Nova for aktier i Affitech A/S på grundlag af accept fra NASDAQ OMX Copenhagen af anmodning om afnotering
July 17, 2012 04:03 ET
|
Affitech A/S
København, d. 17. juli 2012
På vegne af Trans Nova Investments Limited offentliggøres herved pressemeddelelse og tilbudsdokument vedrørende nyt frivilligt betinget offentligt købstilbud til...
![NASDAQ OMX Copenhage](/news-release/logo/225548/0/225548.jpg?lastModified=12%2F09%2F2016%2022%3A50%3A34&size=2)
NASDAQ OMX Copenhagen to accept delisting request provided a new offer from Trans Nova
July 06, 2012 08:20 ET
|
Affitech A/S
Copenhagen and Oslo, 6th July, 2012, 2012-07-06 14:20 CEST (GLOBE NEWSWIRE) --
Affitech A/S, (NASDAQ OMX: AFFI), the antibody medicines company, announced today NASDAQ OMX Copenhagen has responded...
![NASDAQ OMX Copenhage](/news-release/logo/225548/0/225548.jpg?lastModified=12%2F09%2F2016%2022%3A50%3A34&size=2)
NASDAQ OMX Copenhagen accepterer afnotering under forudsætning af fornyet købstilbud fra Trans Nova
July 06, 2012 08:20 ET
|
Affitech A/S
København og Oslo, 6. juli 2012, 2012-07-06 14:20 CEST (GLOBE NEWSWIRE) --
Affitech A/S, (NASDAQ OMX: AFFI), der udvikler antistoflægemidler, meddeler i dag, at NASDAQ OMX Copenhagen har...
![Affitech og IBC Gene](/news-release/logo/225548/0/225548.jpg?lastModified=12%2F09%2F2016%2022%3A50%3A34&size=2)
Affitech og IBC Generium i samarbejdsaftale vedrørende overførsel af MBASTM teknologien
July 01, 2012 13:11 ET
|
Affitech A/S
København og Oslo, 1. juli 2012, 2012-07-01 19:11 CEST (GLOBE NEWSWIRE) --
Affitech A/S, (NASDAQ OMX: AFFI), der udvikler antistoflægemidler, meddeler i dag, at International Biotech Center Generium...
![Affitech and IBC Gen](/news-release/logo/225548/0/225548.jpg?lastModified=12%2F09%2F2016%2022%3A50%3A34&size=2)
Affitech and IBC Generium enter into a technology transfer agreement for the MBASTM technology
July 01, 2012 13:11 ET
|
Affitech A/S
Copenhagen and Oslo, 1st July, 2012, 2012-07-01 19:11 CEST (GLOBE NEWSWIRE) --
Affitech A/S, (NASDAQ OMX: AFFI), the antibody medicines company, announced today that International Biotech Center...